Abakavir: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
 
Baris 111:
* [http://www.pharmgkb.org/guideline/PA166104997 Abacavir dosing guidelines from the Clinical Pharmacogenetics Implementation Consortium (CPIC)]
* [http://www.pharmgkb.org/guideline/PA166104991 Abacavir dosing guidelines from the Dutch Pharmacogenetics Working Group (DPWG)]
[[Kategori:Penghambat transkriptase balik analog nukelosidanukleosida]]
[[Kategori:Purina]]
[[Kategori:Obat Esensial Nasional Indonesia]]